BridgeMD
New treatment option for Complete or Incomplete Paraplegia/quadriplegia
Official title Research on Wireless Brain Implant System for General Control of External Devices
ClinicalTrials.gov ID: NCT06829212
What this study is testing
- What it's testing
- The clinical trial aims to evaluate the safety and efficacy of the minimally invasive, wireless brain-machine interface system (WRS) in enabling general brain control of external devices, such as a cursor and other assistive technologies, for paralyzed and amputee patients. WRS integrates a high-throughput, ultra-flexible neural electrode with an extremely small cross-sectional size-approximately one-hundredth the diameter of a human hair.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Aged 18-80 years (inclusive), any gender.
- Diagnosed with spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis, or other motor neuron diseases causing partial or complete...
- Diagnosis stable for at least 6 months before screening, with the condition present for at least 1 year.
- Willing to follow the study protocol and attend all visits, with or without caregiver assistance.
- Informed consent signed by participant and/or caregiver, with full understanding of the trial's purpose.
You likely can't join if
- Previous implantation of metal objects or devices (except dental implants or non-impacting implants).
- Long-term use of anticoagulants/antiplatelets with insufficient cessation, or abnormal coagulation test results.
- Unable to tolerate anesthesia or surgery.
- Severe neurological disorders or brain injury leading to significant dysfunction.
- Scalp conditions that may impair wound healing.
- Acute or severe infections.
See the full eligibility criteria
- Aged 18-80 years (inclusive), any gender.
- Diagnosed with spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis, or other motor neuron diseases causing partial or complete paralysis, or bilateral upper limb amputation.
- Diagnosis stable for at least 6 months before screening, with the condition present for at least 1 year.
- Willing to follow the study protocol and attend all visits, with or without caregiver assistance.
- Informed consent signed by participant and/or caregiver, with full understanding of the trial's purpose.
- Previous implantation of metal objects or devices (except dental implants or non-impacting implants).
- Long-term use of anticoagulants/antiplatelets with insufficient cessation, or abnormal coagulation test results.
- Unable to tolerate anesthesia or surgery.
- Severe neurological disorders or brain injury leading to significant dysfunction.
- Scalp conditions that may impair wound healing.
- Acute or severe infections.
- Cognitive impairment or psychiatric disorders.
- Severe dysfunction of vital organs, malignancies, or autoimmune diseases.
- Life expectancy under 1 year.
- Drug or alcohol abuse.
- Pregnant, breastfeeding, or planning pregnancy during the study.
- Other conditions deemed unsuitable by the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.